PetIQ, Inc. (PETQ) Misses Q3 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
PetIQ, Inc. Reports Third Quarter 2018 Financial Results
November 13, 2018 4:05 PM ESTThird Quarter Net Sales Increase 117% Year-Over-Year to $131.4 Million Raises Full Year 2018 Net Sales Outlook to Approximately $515 Million
EAGLE, Idaho, Nov. 13, 2018 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and nine months ended September 30, 2018.
Third Quarter 2018 Highlights Compared to Prior Year Period
Record third quarter net sales of $131.4 million, an increase of 117%Net income of $3.9 million compared to $0.9 millionAdjusted EBITDA of... More


